Back to FMR LLC FMR LLC

CLDXCLDX
7 quarters

Position history for FMR LLCFMR LLC's holdings in Celldex Therapeutics, Inc.

FMR LLC holds 3.7M shares of CLDX (Celldex Therapeutics, Inc.), worth $138.5M as of 2026-Q2. The position was decreased (-0.7% shares). CLDX represents 0.0% of FMR LLC's portfolio.

Current Value

$138.5M

Current Shares

3.7M

Total Value Change

+$15.8M

Total Shares Change

-1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3.7M
-0.7%
$138.5M0.0%$37.21
0
2026-Q1
Decreased
3.7M
-23.6%
$118.9M0.0%$28.94
0
2025-Q4
Decreased
4.9M
-1.1%
$133.3M0.0%$26.43
0
2025-Q3
Decreased
5M
-8.8%
$128.4M0.0%$26.19
0
2025-Q2
Increased
5.4M
+1.1%
$110.7M0.0%$20.29
30
2025-Q1
Increased
5.4M
+10.8%
$97.6M0.0%$19.93
33
2024-Q4
New
4.9M
-
$122.8M0.0%$25.12
42

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used